For citations:
Bragina O.D., Larkina M.S., Stasyuk E.S., Chernov V.I., Yusubov M.S., Skuridin V.S., Deyev S.M., Zel’chan R.V., Buldakov M.A., Podrezova E.V., Belousov M.V. The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu. Bulletin of Siberian Medicine. 2017;16(3):25-33. (In Russ.) https://doi.org/10.20538/1682-0363-2017-3-25-33
Email this article 